Infected Blood Inquiry

Sorcha Eastwood Excerpts

Tuesday 19th November 2024 Commons Chamber

[Andrew Gwynne]

The right hon. Gentleman raises an important point. Indeed, it was acknowledged by my right hon. Friend the Paymaster General and Minister for the Cabinet Office in his opening speech that this is just one of a number of scandals that follow a similar pattern—when the scandal has been uncovered, rather than trying to protect the victim, the state has tried to protect itself. It is absolutely crucial that the state learns not just from each individual scandal, but collectively; that it is the same mindset that has led us to all these different scandals with similar outcomes for victims. That level of learning has to be genuinely across Government, and I know my right hon. Friend will lead on that in the Cabinet Office.

The Government will set out our formal response before the end of the year, but given that there is absolutely no time to waste, I want to take this opportunity to update the House on the work already under way to address some of the inquiry’s recommendations. To prevent future harm, the Department continues to explore options to enhance candour and openness across the national health service. To empower patient voices, the NHS is reviewing clinical audits related to haemophilia services to identify any gaps in patient involvement, alongside work on a new clinical service specification, which will set standards for services across England. To protect haemophiliacs, the NHS has convened an expert group to hear advice from the specialised blood disorders clinical reference group. A dedicated taskforce has been set up to consider its recommendations. The General Medical Council is working with NHS England and others to look at ways to ensure that lessons learned are reflected in training for doctors, nurses and other healthcare professionals.

Let me be clear to the House: the Government do not see this scandal in isolation. Sadly, repeated patient safety failings have eroded public confidence in our health and social care system, so we are taking steps to fix the culture of the national health service. My right hon. Friend the Secretary of State for Health and Social Care has been clear that we will not tolerate NHS managers who silence whistleblowers. Openness and honesty are vital to ensuring patient safety. NHS staff must have the confidence to speak out and come forward if they have concerns. There will be no more turning a blind eye to failure.

Our wider reforms to NHS performance will provide greater transparency for the public who pay for it. Measures will ensure that top talent is attracted to the most challenged areas, and persistently failing managers will be sacked. That is about ensuring that the right people are in post to lead our NHS with the resources they need to do their job. If we get that right, we will be able to look back on this moment as a turning point for patient safety and for leadership.

[Sorcha Eastwood (Lagan Valley) (Alliance)]

I apologise, Madam Deputy Speaker; I was in Committee at the start of the debate, but I did have my name down to speak. Some of my constituents were impacted by the scandal, and it has taken them this long to summon the courage to come forward. Obviously, I represent them and Northern Ireland. We have talked about the Hillsborough law and the need for a duty of candour. Does the Minister agree that it is important that that is rolled out not just in England and Wales, but right across the UK, so that, as he said, those families are never again impacted in that way?

[Andrew Gwynne]

I hope that I can reassure the hon. Lady that although health is devolved across the four nations, and I can speak only on behalf of the NHS in England on a number of the recommendations, both the Department of Health and Social Care and the Cabinet Office are working closely and collaboratively with Ministers in the devolved Administrations. Indeed, I and my right hon. Friend the Paymaster General recently had a meeting with Ministers from Scotland, Northern Ireland and Wales to talk about how to take forward the recommendations, on a four-nation basis where possible, and with mutual support across the four nations where there are individual recommendations pertinent to the devolved parts of the United Kingdom. I hope that that reassures her that we are working together. Although I cannot comment on the changes that will be needed for health services in Northern Ireland, which are a matter for the Minister of Health in Northern Ireland, Mike Nesbitt, I am quite certain that those services will carefully and closely consider our work here in England, and the work in other parts of the United Kingdom.

We have waited too long for these actions. People have waited too long for compensation. Indeed, right hon. and hon. Members have waited too long for this debate. More than 3,000 people died before they saw justice; families and our country were let down. There was a level of suffering that is so difficult to comprehend, because questions were not asked at the time, institutions did not face up to the failings, and facts were covered up. Now we know the truth. As we reflect, we are making a concerted effort to improve, because that loss need not be in vain.

I will respond to some of the questions raised throughout the debate, and will refer to other questions directly in the relevant part of my contribution. Should I miss anything because of time constraints, I will write to Members. In opening for the official Opposition, the hon. Member for Kingswinford and South Staffordshire talked about destigmatisation of HIV and hepatitis C. I hope that he understands that the Labour party made a clear manifesto commitment to ending HIV transmission in England by 2030. Officials at the Department of Health and Social Care, the UK Health Security Agency, NHS England and a broad range of system partners are now working together to develop a new HIV action plan, which we aim to publish by summer next year, and destigmatisation will be a key part of that plan.

My hon. Friend the Member for Blyth and Ashington asked about psychological support for family and friends. I reassure him that NHS England has established the infected blood psychological support service in England, which supported its first patients in late August. That includes supporting not just the infected, but the families and friends affected.

I want to turn to departmental failings. The report outlines a comprehensive condemnation of the organisation of blood services, licensing decisions, blood safety and patient safety, with harm compounded by the reaction and handling of Government. I again recognise humbly the criticism of the Department that I stand at this Dispatch Box to represent and its predecessors, and I am committed to ensuring that a tragedy such as the infected blood scandal can never happen again. This Government will prioritise patient safety to ensure that the NHS treats people with the high-quality, safe care they deserve.

Repeated inquiries and investigations have highlighted significant issues with patient safety, which has caused a deterioration in public confidence, as we heard from my hon. Friend the Member for Aldershot (Alex Baker) in an earlier intervention. We must absolutely fix that. The Health Secretary has been clear that we will not tolerate NHS managers who silence whistleblowers. A culture of openness and honesty is vital to ensure patient safety. We want NHS staff to have the confidence to speak out, and we will give them that.

The hon. Member for Eastleigh (Liz Jarvis) raised the question of the safety of blood products. While no medical treatment can be completely risk-free, current safety standards for blood donation and transfusion are rigorous, and England’s blood supply is one of the safest in the world. Processes are in place throughout the blood donation journey to ensure the safety of blood and blood products, including the donation safety check form, testing for specific infections, donor deferrals, regulations and informed consent. According to Serious Hazards of Transfusion, the risk of serious harm because of blood transfusion in the United Kingdom is low, at one in 11,000 blood components issued.

Turning to timelines, so far more than £1 billion has been paid in interim compensation payments to victims of the infected blood scandal. As we heard earlier, applications opened on 24 October for interim payments of £100,000 to the estates of deceased people whose deaths have not been recognised. Parliament has now approved regulations that give the Infected Blood Compensation Authority the powers necessary to pay compensation through the core route to the infected, both living and deceased. The Infected Blood Compensation Authority has begun to process its first claimants under the infected blood compensation scheme.